...
首页> 外文期刊>Inorganic Chemistry >Novel Oximato-Bridged Platinum(II) Di- and Trimer(s): Synthetic, Structural, and in Vitro Anticancer Activity Studies
【24h】

Novel Oximato-Bridged Platinum(II) Di- and Trimer(s): Synthetic, Structural, and in Vitro Anticancer Activity Studies

机译:新型Oximato桥铂(II)二聚体和三聚体:合成,结构和体外抗癌活性的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Novel platinum complexes of trans geometry [PtCl2{(Z)-R(H)C═NOH}2] [R = Me (1), Et (3)] and [PtCl2{(E)-R(H)C═NOH}{(Z)-R(H)C═NOH}] [R = Me (2), Et (4)] as well as the classic trans-[PtCl2(R2C═NOH)2] [R = Me, Et] were reacted with an equivalent amount of silver acetate in acetone solution at ambient temperature, resulting in formation of unprecedented head-to-tail-oriented oximato-bridged dimers [PtCl{μ-(Z)-R(H)C═NO}{(Z)-R(H)C═NOH}]2 [R = Me (5), Et (7)], [PtCl{μ-(Z)-R(H)C═NO}{(E)-R(H)C═NOH}]2 [R = Me (6), Et (8)], and [PtCl(μ-R2C═NO)(R2C═NOH)]2 [R = Me (9), Et (10)], correspondingly. The dimeric species feature a unique six-membered diplatinacycle and represent the first example of oxime ligands coordinated to platinum via the oxygen atom. All complexes were characterized by elemental analyses, electrospray ionization mass spectrometry, IR and multinuclear (1H, 13C, and 195Pt) NMR spectroscopy, as well as X-ray diffraction in the cases of dimers 6 and 9. Furthermore, the crystal and molecular structures of a trimeric oximato-bridged complex 11 comprising three platinum units connected in a chain way were established. The cytotoxicity of both dimers and the respective monomers was comparatively evaluated in three human cancer cell lines: cisplatin-sensitive CH1 cells as well as cisplatin-resistant SW480 and A549 cells, whereupon structure–activity relationships were drawn. Thus, it was found that dimerization results in a substantial (up to 7-fold) improvement of IC50 values of (aldoxime)PtII compounds, whereas for the analogous complexes featuring ketoxime ligands the reverse trend was observed. Remarkably, the novel dimers yielded no cross-resistance with cisplatin in SW480 cells, exhibiting up to 2-fold enhanced cytotoxicity in comparison with the CH1 cell line and thereby possessing a promising potential to overcome resistance toward platinum anticancer drugs. The latter point was also confirmed by investigating the potency of apoptosis induction in the case of one monomer as well as one dimer; the investigated complexes proved to be strong apoptotic agents which could induce cell death even in the cisplatin-resistant SW480 cell line.
机译:反式[PtCl2 {(Z)-R(H)C═NOH} 2]的新型铂配合物[R = Me(1),Et(3)]和[PtCl2 {(E)-R(H)C═ NOH} {(Z-R(H)C═NOH}] [R = Me(2),Et(4)]以及经典的反式-[PtCl2(R2C═NOH)2] [R = Me, Et]在室温下与等量的乙酸银在丙酮溶液中反应,导致形成前所未有的头尾相接的肟基桥连二聚体[PtCl {μ-(Z)-R(H)C═NO } {(Z-R(H)C═NOH}] 2 [R = Me(5),Et(7)],[PtCl {μ-(Z)-R(H)C═NO} {(E )-R(H)C═NOH}] 2 [R = Me(6),Et(8)]和[PtCl(μ-R2C═NO)(R2C═NOH)] 2 [R = Me(9) ,等(10)]。该二聚体物种具有独特的六元双铂环,并代表通过氧原子与铂配位的肟配体的第一个实例。所有配合物的特征在于元素分析,电喷雾电离质谱,IR和多核(1H,13C和195Pt)NMR光谱,以及二聚体6和9的X射线衍射。此外,晶体和分子结构建立了三聚肟基桥接的复合物11,其包括三个以链方式连接的铂单元。在三种人类癌细胞系中对二聚体和相应单体的细胞毒性进行了比较评估:顺铂敏感的CH1细胞以及顺铂耐药的SW480和A549细胞,由此得出了结构-活性关系。因此,发现二聚化导致(醛肟)PtII化合物的IC 50值显着(高达7倍)提高,而对于具有酮肟配体的类似配合物则观察到相反的趋势。值得注意的是,新型二聚体在SW480细胞中未与顺铂产生交叉耐药性,与CH1细胞系相比显示出高达2倍的细胞毒性增强,因此具有克服铂类抗癌药耐药性的潜力。通过研究在一种单体和一种二聚体的情况下的细胞凋亡诱导能力也证实了后一点。被研究的复合物被证明是强凋亡因子,即使在顺铂耐药的SW480细胞系中也可以诱导细胞死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号